United States Botulinum Toxin Market Size is Anticipated to Reach USD 8.50 Billion by 2035, Growing at a CAGR of 4.98% from 2025 to 2035. The U.S. botulinum toxin market growth is driven by rising demand for non-invasive cosmetic procedures, increased awareness of aesthetic and therapeutic benefits, and expanding applications in medical conditions like migraines and muscle disorders. Advances in safer, longer-lasting formulations and greater availability through specialty clinics also boost adoption, supported by favourable regulatory frameworks and growing disposable incomes.